166 related articles for article (PubMed ID: 8395335)
1. Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma.
Barnard GF; Staniunas RJ; Mori M; Puder M; Jessup MJ; Steele GD; Chen LB
Cancer Res; 1993 Sep; 53(17):4048-52. PubMed ID: 8395335
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma.
Barnard GF; Staniunas RJ; Bao S; Mafune K; Steele GD; Gollan JL; Chen LB
Cancer Res; 1992 Jun; 52(11):3067-72. PubMed ID: 1350508
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation.
Kondoh N; Schweinfest CW; Henderson KW; Papas TS
Cancer Res; 1992 Feb; 52(4):791-6. PubMed ID: 1339304
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma.
Niwa Y; Matsumura M; Shiratori Y; Imamura M; Kato N; Shiina S; Okudaira T; Ikeda Y; Inoue T; Omata M
Hepatology; 1996 Jun; 23(6):1384-92. PubMed ID: 8675155
[TBL] [Abstract][Full Text] [Related]
5. Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression.
Mafune K; Ravikumar TS; Wong JM; Yow H; Chen LB; Steele GD
Cancer Res; 1990 Jul; 50(13):3888-91. PubMed ID: 2141294
[TBL] [Abstract][Full Text] [Related]
6. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy.
Husain I; Mohler JL; Seigler HF; Besterman JM
Cancer Res; 1994 Jan; 54(2):539-46. PubMed ID: 8275492
[TBL] [Abstract][Full Text] [Related]
7. Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer.
Lu XQ; Levy M; Weinstein IB; Santella RM
Cancer Res; 1991 Dec; 51(23 Pt 1):6231-5. PubMed ID: 1933883
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2.
Henry JL; Coggin DL; King CR
Cancer Res; 1993 Mar; 53(6):1403-8. PubMed ID: 8095182
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin fusion proteins are overexpressed in colon cancer but not in gastric cancer.
Barnard GF; Mori M; Staniunas RJ; Begum NA; Bao S; Puder M; Cobb J; Redman KL; Steele GD; Chen LB
Biochim Biophys Acta; 1995 Dec; 1272(3):147-53. PubMed ID: 8541345
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression.
D'Errico A; Garbisa S; Liotta LA; Castronovo V; Stetler-Stevenson WG; Grigioni WF
Mod Pathol; 1991 Mar; 4(2):239-46. PubMed ID: 1646457
[TBL] [Abstract][Full Text] [Related]
12. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis.
Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB
Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067
[TBL] [Abstract][Full Text] [Related]
13. Detection of mRNA for ribosomal phosphoprotein P2 in normal colon and colonic tumours by in situ hybridization.
Harvie R; Elvin P; McArdle C; Morten JE; McNicol AM
J Pathol; 1991 May; 164(1):67-73. PubMed ID: 2056390
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma.
Kondoh N; Shuda M; Tanaka K; Wakatsuki T; Hada A; Yamamoto M
Anticancer Res; 2001; 21(4A):2429-33. PubMed ID: 11724303
[TBL] [Abstract][Full Text] [Related]
15. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
Guo XZ; Friess H; Di Mola FF; Heinicke JM; Abou-Shady M; Graber HU; Baer HU; Zimmermann A; Korc M; Büchler MW
Hepatology; 1998 Dec; 28(6):1481-8. PubMed ID: 9828210
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.
Kim MY; Park E; Park JH; Park DH; Moon WS; Cho BH; Shin HS; Kim DG
Oncogene; 2001 Jul; 20(33):4568-75. PubMed ID: 11494152
[TBL] [Abstract][Full Text] [Related]
18. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas.
Kitadai Y; Ellis LM; Takahashi Y; Bucana CD; Anzai H; Tahara E; Fidler IJ
Clin Cancer Res; 1995 Oct; 1(10):1095-102. PubMed ID: 9815899
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
